• Profile
Close

Screening for chronic prostatitis pathogens using high‐throughput next‐generation sequencing

The Prostate Mar 19, 2020

Wu Y, et al. - Researchers recruited 33 individuals with chronic prostatitis (CP) III and 30 healthy men in order to apply high‐throughput next‐generation sequencing to screen for potential pathogens correlated with NIH category III CP (CP III). This study conducted high‐throughput next‐generation sequencing to identify the sequence variations and the relative abundance of the bacterial 16S ribosomal variable region and fungal internal transcribed spacer region in all samples. They applied bioinformatics software and databases for data analysis, and differences with P < .05 were considered statistically significant. There was no potential pathogens in diagnosed patients with CP III. Before and after infection, the expressed prostatic secretions may be free from bacteria. Variations in the urinary tract microbiome may unsettle the microecological balance of the urinary system, thereby leading to CP III. It was considered that true pathogens of CP III may not be prokaryotic or eukaryotic microorganisms, further study is needed to evaluate the noncellular microbes.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
  • 55 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Unlimited access to original articles by experts
  • Nonloggedinlock icon
    Secure: we never sell your data
  • Signing up takes less than 2 mins
Try M3 India / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay